We are live on ! Find out more
AIM

Aigen Investment Management Portfolio holdings

AUM $389M
1-Year Est. Return 16.77%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$677M
AUM Growth
-$50M
Cap. Flow
-$67.1M
Cap. Flow %
-9.92%
Top 10 Hldgs %
11.02%
Holding
1,031
New
439
Increased
126
Reduced
146
Closed
320

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$10.2M
2
KMB icon
Kimberly-Clark
KMB
+$8.57M
3
SBAC icon
SBA Communications
SBAC
+$7.81M
4
PCG icon
PG&E
PCG
+$5.73M
5
AAP icon
Advance Auto Parts
AAP
+$5.62M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$15.6M
2
PFE icon
Pfizer
PFE
+$14.6M
3
D icon
Dominion Energy
D
+$13.4M
4
JNJ icon
Johnson & Johnson
JNJ
+$12.9M
5
CDNS icon
Cadence Design Systems
CDNS
+$9.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.25%
2 Technology 16.12%
3 Industrials 11.55%
4 Financials 11.01%
5 Healthcare 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOS icon
276
A.O. Smith
AOS
$8.7B
$675K 0.1%
+9,278
New +$635K
TREX icon
277
Trex
TREX
$5.01B
$675K 0.1%
10,293
+5,603
+119% +$313K
JKS
278
JinkoSolar
JKS
$891M
$674K 0.1%
+15,178
New +$687K
NAPA
279
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$673K 0.1%
+51,887
New +$736K
KRYS icon
280
Krystal Biotech
KRYS
$9.66B
$672K 0.1%
+5,725
New +$585K
SAIC icon
281
Saic
SAIC
$5.35B
$672K 0.1%
+5,975
New +$621K
MED icon
282
Medifast
MED
$141M
$670K 0.1%
+7,269
New +$647K
INFY icon
283
Infosys
INFY
$50.7B
$661K 0.1%
+41,119
New +$643K
MS icon
284
Morgan Stanley
MS
$340B
$660K 0.1%
+7,731
New +$661K
IONS icon
285
Ionis Pharmaceuticals
IONS
$9.4B
$657K 0.1%
+16,019
New +$616K
DTM icon
286
DT Midstream
DTM
$13.4B
$654K 0.1%
+13,196
New +$631K
ACLX
287
DELISTED
Arcellx
ACLX
$650K 0.1%
+20,564
New +$786K
ACVA icon
288
ACV Auctions
ACVA
$1.3B
$647K 0.1%
+37,456
New +$573K
CCJ icon
289
Cameco
CCJ
$42.4B
$641K 0.09%
20,481
+9,521
+87% +$268K
FIVN icon
290
FIVE9
FIVN
$2.54B
$639K 0.09%
+7,756
New +$521K
BIIB icon
291
Biogen
BIIB
$30.7B
$638K 0.09%
+2,240
New +$667K
PERI icon
292
Perion Network
PERI
$386M
$634K 0.09%
+20,674
New +$710K
SQSP
293
DELISTED
Squarespace, Inc.
SQSP
$628K 0.09%
+19,911
New +$601K
ACGL icon
294
Arch Capital
ACGL
$33.6B
$622K 0.09%
+8,314
New +$601K
BMRN icon
295
BioMarin Pharmaceuticals
BMRN
$12.4B
$621K 0.09%
+7,170
New +$675K
PAYX icon
296
Paychex
PAYX
$42.7B
$612K 0.09%
+5,474
New +$599K
BRSL
297
Brightstar Lottery PLC
BRSL
$2.03B
$611K 0.09%
+19,150
New +$532K
KSS icon
298
Kohl's
KSS
$2.19B
$607K 0.09%
+26,328
New +$570K
TMUS icon
299
T-Mobile US
TMUS
$190B
$606K 0.09%
4,360
-28,372
-87% -$3.98M
CABO icon
300
Cable One
CABO
$212M
$601K 0.09%
915
+401
+78% +$270K
10 11
12
13 14

Similar funds

SA
Sicart Associates New York $389M AUM 42.46% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
SI
Schusterman Interests Tulsa, Oklahoma $391M AUM 33.81% 1-Year Est. Return
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Aigen Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Aigen Investment Management held 1,031 positions worth $677M, down 6.9% from $727M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aigen Investment Management withdrew a net $67.1M in Q2 2023, closing 320 positions and reducing 146 holdings. Its most notable exit was Pfizer, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aigen Investment Management opened a new position in Apple worth $11.4M.

  • Aigen Investment Management's largest Q2 2023 buy was Apple: 58,654 shares worth $11.4M.
  • Aigen Investment Management added most to Advance Auto Parts in Q2 2023, an estimated $5.62M increase.
  • Aigen Investment Management's biggest Q2 2023 reduction was Broadcom, cutting an estimated $15.6M.
  • Aigen Investment Management fully exited Pfizer in Q2 2023, selling an estimated $14.6M.
  • Aigen Investment Management's ten largest holdings make up 11% of its $677M portfolio in Q2 2023.
  • Aigen Investment Management opened 439 new positions and closed 320 in Q2 2023.
  • Aigen Investment Management's portfolio value fell 6.9% quarter-over-quarter to $677M.

Based on Aigen Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.